脓毒症休克-话题@MedSci

#脓毒症休克#

15篇内容 | 1364人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2217338, encodeId=9a11221e338c3, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a> <a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a> <a href='/topic/show?id=8a4e11e08394' target=_blank style='color:#2F92EE;'>#OCCCM 2024#</a>, objectTitle=OCCCM 2024 | 专访尹海燕教授：激素治疗脓毒症休克：剂量、疗程与未来趋势, objectType=article, longId=836715, objectId=2cc7836e15e1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240729/1722219972769_92910.png, objectUrl=/article/show_article.do?id=2cc7836e15e1, replyNumber=0, likeNumber=58, createdTime=2024-07-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2cc7836e15e1, moduleTitle=OCCCM 2024 | 专访尹海燕教授：激素治疗脓毒症休克：剂量、疗程与未来趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cc7836e15e1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215563, encodeId=8bb422155632d, content=<a href='/topic/show?id=7a2f851921d' target=_blank style='color:#2F92EE;'>#脓毒症#</a> <a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=【今日分享】2024年《儿童脓毒症和脓毒性休克的国际共识Phoenix标准》解读, objectType=article, longId=835081, objectId=28cd83508181, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721275060643_8538692.png, objectUrl=/article/show_article.do?id=28cd83508181, replyNumber=0, likeNumber=39, createdTime=2024-07-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=28cd83508181, moduleTitle=【今日分享】2024年《儿童脓毒症和脓毒性休克的国际共识Phoenix标准》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28cd83508181)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194762, encodeId=8cce2194e6291, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a> <a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a> <a href='/topic/show?id=2ee51125840a' target=_blank style='color:#2F92EE;'>#毛细血管再充盈时间#</a>, objectTitle=脓毒症休克患者的毛细血管再充盈时间监测, objectType=article, longId=816746, objectId=5271816e461d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-leading-a-medical-team-at-hospital-DQZSHGT.jpg, objectUrl=/article/show_article.do?id=5271816e461d, replyNumber=0, likeNumber=63, createdTime=2024-03-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5271816e461d, moduleTitle=脓毒症休克患者的毛细血管再充盈时间监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5271816e461d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182833, encodeId=a5bc218283385, content=<a href='/topic/show?id=58ee50609ee' target=_blank style='color:#2F92EE;'>#微循环#</a> <a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a> <a href='/topic/show?id=328411029645' target=_blank style='color:#2F92EE;'>#流体动力学#</a>, objectTitle=脓毒症休克中间质的作用：理解流体动力学的关键？, objectType=article, longId=807790, objectId=627180e790b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=627180e790b8, replyNumber=0, likeNumber=72, createdTime=2024-01-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=627180e790b8, moduleTitle=脓毒症休克中间质的作用：理解流体动力学的关键？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=627180e790b8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1661221, encodeId=27531661221bc, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=NEJM：脓毒症休克时应该限制性液体管理吗？, objectType=article, longId=729875, objectId=7579e2987517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7579e2987517, replyNumber=0, likeNumber=81, createdTime=2023-05-29, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7579e2987517, moduleTitle=NEJM：脓毒症休克时应该限制性液体管理吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7579e2987517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661220, encodeId=4523166122050, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=Chest：实体瘤和脓毒症休克患者28天死亡率的结局和预测因素, objectType=article, longId=729286, objectId=9833e292862f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9833e292862f, replyNumber=0, likeNumber=0, createdTime=2022-08-04, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9833e292862f, moduleTitle=Chest：实体瘤和脓毒症休克患者28天死亡率的结局和预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9833e292862f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661219, encodeId=afcf166121955, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=Crit Care：细菌培养阴性和阳性的脓毒症或脓毒症休克患者结局哪个好？, objectType=article, longId=211481, objectId=115d2114814c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=115d2114814c, replyNumber=0, likeNumber=99, createdTime=2022-02-08, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=115d2114814c, moduleTitle=Crit Care：细菌培养阴性和阳性的脓毒症或脓毒症休克患者结局哪个好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=115d2114814c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661217, encodeId=2ad4166121e70, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=新型冠状病毒感染所致脓毒症休克的处理要点, objectType=article, longId=190525, objectId=54dd190525b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54dd190525b7, replyNumber=0, likeNumber=95, createdTime=2020-09-04, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54dd190525b7, moduleTitle=新型冠状病毒感染所致脓毒症休克的处理要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54dd190525b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661216, encodeId=0a6116612169a, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=JAMA：VC及VB1对脓毒症休克患者无益, objectType=article, longId=186620, objectId=96cf18662080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96cf18662080, replyNumber=0, likeNumber=70, createdTime=2020-10-05, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96cf18662080, moduleTitle=JAMA：VC及VB1对脓毒症休克患者无益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96cf18662080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661218, encodeId=1397166121894, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=Heart：脓毒症休克患者右心室功能障碍与预后不良之间的关联, objectType=article, longId=197339, objectId=d97519e339e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d97519e339e0, replyNumber=0, likeNumber=0, createdTime=2020-12-24, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d97519e339e0, moduleTitle=Heart：脓毒症休克患者右心室功能障碍与预后不良之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d97519e339e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661214, encodeId=25031661214dc, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?, objectType=article, longId=174655, objectId=52951e465521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52951e465521, replyNumber=0, likeNumber=96, createdTime=2019-07-07, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52951e465521, moduleTitle=脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52951e465521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661215, encodeId=a2f5166121511, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=Clinica Chimica Acta：采用新型LC-MS/MS法测定脓毒症休克时血浆缓激肽浓度, objectType=article, longId=177033, objectId=f5b61e703365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5b61e703365, replyNumber=0, likeNumber=80, createdTime=2020-07-01, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5b61e703365, moduleTitle=Clinica Chimica Acta：采用新型LC-MS/MS法测定脓毒症休克时血浆缓激肽浓度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5b61e703365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661212, encodeId=0ec216612129e, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=Health Technol Assess：脓毒症休克儿童：限制性液体单次给予10 ml vs 20 ml, objectType=article, longId=151459, objectId=493115145990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=493115145990, replyNumber=0, likeNumber=70, createdTime=2019-02-03, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=493115145990, moduleTitle=Health Technol Assess：脓毒症休克儿童：限制性液体单次给予10 ml vs 20 ml, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=493115145990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661213, encodeId=3819166121335, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=脓毒症和脓毒症休克治疗策略的进化 - 四个早期！, objectType=article, longId=151990, objectId=8f6a15199074, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f6a15199074, replyNumber=0, likeNumber=0, createdTime=2018-11-09, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f6a15199074, moduleTitle=脓毒症和脓毒症休克治疗策略的进化 - 四个早期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f6a15199074)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661211, encodeId=08da166121183, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=NEJM：脓毒症休克患者激素辅助治疗, objectType=article, longId=127372, objectId=01e412e3724a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01e412e3724a, replyNumber=0, likeNumber=71, createdTime=2018-02-19, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01e412e3724a, moduleTitle=NEJM：脓毒症休克患者激素辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01e412e3724a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661210, encodeId=99ba166121066, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=Crit Care Med：及时的晶体复苏对脓毒症和脓毒症休克的影响, objectType=article, longId=106309, objectId=4e04106309e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e04106309e0, replyNumber=0, likeNumber=91, createdTime=2017-12-30, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e04106309e0, moduleTitle=Crit Care Med：及时的晶体复苏对脓毒症和脓毒症休克的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e04106309e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661209, encodeId=a131166120901, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=J Intensive Care：被动抬腿试验：无创监测可以指导脓毒症休克复苏吗？, objectType=article, longId=104329, objectId=d26a10432966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d26a10432966, replyNumber=0, likeNumber=80, createdTime=2018-03-19, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d26a10432966, moduleTitle=J Intensive Care：被动抬腿试验：无创监测可以指导脓毒症休克复苏吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d26a10432966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661208, encodeId=cf7e1661208ed, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=CHEST：脓毒症休克中血液各标志物的临床意义, objectType=article, longId=88149, objectId=9aee88149b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9aee88149b2, replyNumber=0, likeNumber=85, createdTime=2017-09-06, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9aee88149b2, moduleTitle=CHEST：脓毒症休克中血液各标志物的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9aee88149b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661207, encodeId=c929166120eac, content=<a href='/topic/show?id=8f80851950a' target=_blank style='color:#2F92EE;'>#脓毒症休克#</a>, objectTitle=JAMA：脓毒症休克的新定义和临床评价标准, objectType=article, longId=63685, objectId=36996368528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36996368528, replyNumber=0, likeNumber=73, createdTime=2016-06-25, rootId=0, userName=1249842em17(暂无昵称), userId=f78125230878, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36996368528, moduleTitle=JAMA：脓毒症休克的新定义和临床评价标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36996368528)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

脓毒症休克

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#激素治疗# #脓毒症休克# #OCCCM 2024#

OCCCM 2024 | 专访尹海燕教授：激素治疗脓毒症休克：剂量、疗程与未来趋势

2024-07-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#脓毒症# #脓毒症休克#

【今日分享】2024年《儿童脓毒症和脓毒性休克的国际共识Phoenix标准》解读

2024-07-18发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#脓毒症休克# #CRT# #毛细血管再充盈时间#

脓毒症休克患者的毛细血管再充盈时间监测

2024-03-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#微循环# #脓毒症休克# #流体动力学#

脓毒症休克中间质的作用：理解流体动力学的关键？

2024-01-20发表于陕西省

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

NEJM：脓毒症休克时应该限制性液体管理吗？

2023-05-29

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

Chest：实体瘤和脓毒症休克患者28天死亡率的结局和预测因素

2022-08-04

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

Crit Care：细菌培养阴性和阳性的脓毒症或脓毒症休克患者结局哪个好？

2022-02-08

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

新型冠状病毒感染所致脓毒症休克的处理要点

2020-09-04

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

JAMA：VC及VB1对脓毒症休克患者无益

2020-10-05

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

Heart：脓毒症休克患者右心室功能障碍与预后不良之间的关联

2020-12-24

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?

2019-07-07

1249842em17(暂无昵称) (审核中...)

前往app查看评论内容

#脓毒症休克#

Clinica Chimica Acta：采用新型LC-MS/MS法测定脓毒症休克时血浆缓激肽浓度

2020-07-01

1249842em17(暂无昵称) (审核中...)